In its latest financial report, Monte Rosa Therapeutics has announced a significant partnership with Novartis, alongside progress in its pipeline of drug candidates. The partnership involves a global ...

Big pharmaceutical companies including the two big Swiss players, Roche and Novartis, had a lot at stake in the US ...

Sioux Falls, SD– The annual Sioux Falls Jingle Bell Run returns to Downtown Sioux Falls on Black Friday — November 29th with the goal of raising $30,000. This family-friendly, holiday-themed 5K or 1.5 ...

Jimenez served as CEO of Novartis for eight years before founding Aditum in 2019 with another Big Pharma alum, Mark Fishman, ...

Kikuchi–Fujimoto disease (KFD), histiocytic necrotising lymphadenitis, is a benign and self-limiting disease characterised ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

Changes in the make-up of the gut microbiome are linked to the onset of clinically evident rheumatoid arthritis in those at risk of the disease because of genetic, environmental, or immunological ...

The daylong leadership conference touched on numerous topics relevant to medical marketers, pharma executives and media ...

By snugly wrapping around neurons, these devices could help scientists probe subcellular regions of the brain, and might even ...

Ionis Pharmaceuticals posted better-than-expected revenue in the third quarter, but faced challenges as it prepares to bring ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is ...